Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Cytoreductive Surgery × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 577 Ovarian Neoplasms 393 Endometrial Neoplasms 255 Breast Neoplasms 159 Uterine Cervical Dysplasia 119 Neoplasms 79 Carcinoma, Ovarian Epithelial 70 Vulvar Neoplasms 61 Uterine Neoplasms 61 Papillomavirus Infections 61 Prostatic Neoplasms 57 Fallopian Tube Neoplasms 52 Colorectal Neoplasms 51 Lung Neoplasms 41 Peritoneal Neoplasms 37 Colonic Neoplasms 37 Pancreatic Neoplasms 34 Vaginal Neoplasms 32 Urinary Bladder Neoplasms 32 Gynecologic Cancer 30 Head and Neck Neoplasms 29 Stomach Neoplasms 27 Hereditary Breast and Ovarian Cancer Syndrome 26 Pelvic Neoplasms 25 Rectal Neoplasms 24 Motor Activity 24 Sarcoma 23 Melanoma 23 Esophageal Neoplasms 21 Testicular Neoplasms 20

Interventions

Fluorodeoxyglucose F18 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05390021 2024-04-02

PET/MRI in Endometrial Cancer

Massachusetts General Hospital

Phase NA Withdrawn

Cytoreductive Surgery

Data powered by HemOnc (CC BY 4.0) Colophon ⚡